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What	is	the	best	initial	
treatment	for	orbital	cellulitis	
in	children?
z	Evidence	summary
Orbital cellulitis is a serious soft-tissue 
infection of childhood with very differ-
ent etiologies. 
• Periorbital (or preseptal) celluli-
tis is synonymous with stage i orbital 
cellulitis, in which there is induration, 
erythema, warmth, and tenderness of 
the periorbital soft tissues, usually sec-
ondary to external inoculation, but the 
inflammation does not extend into the 
bony orbit. 
• Stages ii, iii, and iV orbital cel-
lulitis are progressively more invasive 
infections that generally arise from the 
sinuses; they may involve the retro-or-
		
Although antibiotics are the best initial 
treatment, surgical intervention is 
warranted when a child has:  
•  visual impairment, complete 
ophthalmoplegia, or well-defined 
abscess on presentation, or 
•  no clearly apparent clinical improvement 
by 24 hours (strength of recommendation 
[sor]: c, based on patient-oriented 
case-series studies). 
 target antimicrobial therapy toward 
the common pathogens associated with 
predisposing factors for orbital cellulitis, 
such as sinusitis—and pay attention to 
local resistance patterns (sor: c, based 
on patient-oriented case series).
rare but serious risk factors
the incidence of Haemophilus influenzae–
related periorbital cellulitis appears to have 
plummeted with the advent of Hib vaccine. 
And while no national data have been 
published, case series support my clinical 
observation that the overall incidence of 
periorbital cellulitis has dropped as well.
 the arrival of heptavalent 
pneumococcal vaccine may further 
contribute to its welcome scarcity. take 
this changing bacteriology—in conjunction 
with local resistance patterns—into account 
when considering antibiotic coverage.
 When confronted by the rare case 
of periorbital cellulitis, I always consider 
risk factors that may change my 
management, such as immunization status 
and asplenia. Also, meningitis is a rare 
but serious complication, so I also keep 
meningitis risk factors in mind, such as 
immunosuppression, coincident trauma, or 
a poor response to initial medical therapy.
 Finally, any question of orbital 
involvement should prompt an emergent 
consultation.
Peter C. Smith, MD
rose Family Medicine residency, university 
of Colorado Health sciences Center, Denver
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“I always consider 
risk factors that 
may change  
management, such 
as immunization 
status, asplenia, 
and risk factors  
for meningitis”
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bital area. These stages of orbital cel-
lulitis can cause proptosis, decrease 
visual acuity, or appear as abscesses on 
computed tomography scan.1,2 
Staged	treatment
Many retrospective studies of stage II–IV 
orbital cellulitis with relatively few sub-
jects and small prospective case series have 
been published with common themes for 
management recommendations: 
•  early intravenous antibiotics (likely 
for an inpatient), and 
•  involvement of otolaryngology and 
ophthalmology specialists. 
No head-to-head trials have been 
completed to evaluate efficacy of specific 
antimicrobial regimens. 
oral antibiotics. First, treat stage I or-
bital cellulitis with oral antibiotics. 
iV antibiotics. Modify treatment to 
intravenous antibiotics when there is no 
improvement within 24 hours or if you 
discover any characteristic of more severe 
orbital cellulitis. 
Medical management of stage II–IV 
orbital cellulitis with intravenous antibiot-
ics is the current standard of care until it is 
clear that one of the following is present:
• no improvement by 24 to 48 hours
• visual impairment
• complete ophthalmoplegia, or
• well-defined periosteal abscess.1,2
Surgery. For refractory cases, surgical 
decompression will likely be required. 
The evidence. A small case series 
(n=9) found 21 children admitted to 
hospital for preseptal cellulitis, of whom 
4 later were diagnosed with orbital cel-
lulitis. There was a total of 9 cases of or-
bital cellulitis; however, only 1 required 
operative management of orbital cel-
lulitis.3 In a prospective study to evalu-
ate medical management (n=23), 87% 
of patients responded to intravenous 
antibiotics.4 No statistically significant 
long-term difference in subperiosteal 
abscesses (as a complication of orbital 
cellulitis) was found in another retro-
spective study comparing medical to 
surgical management.5
Target	the	likely	pathogens
Direct antimicrobial therapy toward com-
mon pathogens for likely sources of infec-
tion, paying attention to local resistance 
patterns and the pathogens usually associ-
ated with sinusitis (TablE).1,2,6–8 
A retrospective case series of 94 pa-
tients of all ages in China implicated 
Staphylococcus aureus and streptococcal 
species based on cultures taken from eye 
purulence and abscesses.6 Another retro-
spective case series from Vanderbilt (n=80) 
found streptococci as the most common 
cause, based on blood and wound cultures 
in the Hib vaccination era; however, only 
12 wounds returned positive cultures.7
Steroids	have	no	proven	benefit
Systemic steroids have no proven ben-
efit in the treatment of pediatric orbital 
Choose	antibiotic	based	on	cause	and	likely	pathogen1,2,6–8
anTecedenT eVenT likely PaThoGenS BeST druGS 
acute sinusitis streptococcus pneumoniae  Penicillinase-resistant penicillins 
 Haemophilus influenzae  
 Moraxella catarrhalis
Trauma staphylococcus aureus  Penicillinase-resistant penicillins
 group A b-hemolytic streptococci  First-generation cephalosporins
 Increasing concern for  Consider drugs appropriate for  
    methicillin-resistant S aureus    methicillin-resistant S aureus
chronic sinusitis Anaerobes Metronidazole 
  Clindamycin
table
Target common 
pathogens for  
the likely source  
of infection—  
and pay attention 
to local resistance 
patterns
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cellulitis with subperiosteal abscess. 
A small retrospective cohort study 
of the benefit of intravenous steroids in 
addition to antibiotics showed no de-
crease in hospital stay or need for surgi-
cal decompression (n=23, P=.26 and .20, 
respectively).9 Without prospective data 
and a power analysis, lack of benefit of 
steroids cannot be definitively shown.
Recommendations	from	others
infectious disease Society of america. The 
guidelines for the management of skin 
and soft-tissue infections implicate b-
hemolytic streptococci as the most com-
mon cellulitis pathogen, but also recom-
mend empiric coverage against S aureus. 
Periorbital and orbital cellulitis are not 
specifically addressed in these guidelines, 
but oral dicloxacillin, cephalexin, clinda-
mycin, or erythromycin are recommended 
for superficial cellulitis, provided there is 
no known resistance to these antibiotics. 
Intravenous penicillinase-resistant 
penicillins (nafcillin) or a first-generation 
cephalosporin (cefazolin) may be used for 
more severe infections. 
For penicillin-allergic patients, the 
IDSA recommends clindamycin or vanco-
mycin.10
Sanford Guide to Antimicrobial Therapy. 
Nafcillin plus ceftriaxone and metronida-
zole is the recommended treatment for or-
bital cellulitis. 
For patients allergic to penicillin, van-
comycin plus levofloxacin and metronida-
zole are recommended.8
Neither the American Academy of 
Ophthalmology nor the International 
Council of Ophthalmology offers clinical 
statements on orbital cellulitis. n
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